Contrast-enhanced magnetic resonance using mangafodipir compared with standard T2W MRC sequences: A pictorial essay

Journal of Magnetic Resonance Imaging

Volumn 20, Issue 2, 2004, Pages 256-263

  Sheppard, Declan ^a,b   Allan, Lynsay ^a   Martin, Pat ^a   McLeay, Trudy ^a   Milne, Wendy ^a   Houston, J Graeme ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

^b Portiuncula Hospital   (Ireland)

Author keywords

Cholangiography; Magnetic resonance, cholangiography (MRC); Magnetic resonance, comparative study; Magnetic resonance, contrast media; Magnetic resonance, three dimensional

Indexed keywords

MANGAFODIPIR;

ANATOMY; ARTICLE; BILE FLOW; BILIARY TRACT DRAINAGE; BILIARY TRACT SCINTISCANNING; CHOLECYSTITIS; CONTRAST ENHANCEMENT; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; STENT; THREE DIMENSIONAL IMAGING;

ADULT; AGED; BILIARY TRACT DISEASES; CHOLANGIOGRAPHY; CONTRAST MEDIA; EDETIC ACID; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE; MIDDLE AGED; PYRIDOXAL PHOSPHATE;

EID: 3242807368     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20114     Document Type: Article

References (18)

1. Wang C, Gordon PB, Hustvedt SO, et al. MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers. Acta Radiologica 1997;38:665-676.
2. Thorstensen O, Isberg B, Jorulf H, Westman L, Svahn U, Venizelos N. MnDPDP enhancement in rabbit liver after intravenous bolus injection and slow infusion. Acta Radiologica 1997;38:717-723.
3. Grant D, Toft KG, Martinsen I, Atzpodien E. Tissue distribution and general safety of MnDPDP in male Beagle dogs, with or without total common bile duct obstruction. Acta Radiologica 1997;38:732-739.
4. Mitchell DG, Alam F. Mangafodipir trisodium: effects on T2- and T1-weighted MR cholangiography. J Magn Reson Imaging 1999;9:366-368.
5. Sheppard DG, Houston JG, Charon J-P, Anderson JS, Milne W, McLeay T. Mn-DPDP-enhanced magnetic resonance cholangiopancreatography (Teslascan MRCP): principles, practice and pitfalls. In: Proceedings of the 86th Annual meeting of RSNA, Chicago, Illinois. 2000. p. 217;666.
6. Kapoor V, Peterson MS, Baron RL, Patel S, Eghtesad B, Fung JJ. Intrahepatic biliary anatomy of living adult liver donors: correlation of mangafodipir trisodium-enhanced MR cholangiography and intraoperative cholangiography. AJR Am J Roentgenol 2002;179:1281-1286.
7. Fayad LM, Holland GA, Bergin D, et al. Functional magnetic resonance cholangiography (fMRC) of the gallbladder and biliary tree with contrast-enhanced magnetic resonance cholangiography. J Magn Reson Imaging 2003;18:449-460.
8. Kim KW, Park M-S, YU J-S, et al. Acute cholecystitis at T2-weighted and manganese-enhanced T1-weighted MR cholangiography: preliminary study. Radiology 2003;227:580-584.
9. Vitellas KM, El-Dieb A, Vaswani K, et al. Detection of bile duct leaks using MR cholangiography with mangafodipir trisodium (Teslascan). J Comput Assist Tomogr 2001;25:102-105.
10. Vitellas KM, El-Dieb A, Vaswani K, et al. Using contrast-enhanced MR cholangiography with IV mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after cholecystectomy: a prospective study of 11 patients. AJR Am J Roentgenol 2002;179:409-416.
11. Lee VS, Rofsky NM, Morgan GR, et al. Volumetric mangafodipir trisodium-enhanced cholangiography to define intrahepatic biliary anatomy. AJR Am J Roentgenol 2001;176:906-908.
12. Sheppard DG, Houston JG, Charon J-P, Anderson JS, Martin P, Allan L. Contrast-enhanced MRCP: a comparison of Gd-BOPTA and mangafodipir. In: Proceedings of the 9th Annual meeting of ISMRM, Glasgow, Scotland, 2001. p. 9-80.
13. Vanzulli A, Rambilla F, De Cobelli F, Messina A, Panizza P, Del Maschio A. Gd-BOPTA enhanced MR cholangiography. ESMRMB 1999;8:29.
14. Bollow M, Taupitz M, Hamm B, Staks T, Wolf KJ, Weinmann HJ. Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in-vivo phase-I clinical evaluation. Eur Radiol 1997;7:126-132.
15. Hirohashi S, Hirohashi R, Uchida H, et al. Optimal dose of hepatobiliary contrast agent for MR cholangiography: experimental study in rats. J Magn Reson Imaging 1998;8:847-852.
16. Foster GS, Hebel D. Optimal delay time for MR imaging of the bilary tree following Mn-DPDP administration. In: Proceedings of the 8th Annual meeting of ISMRM. Denver. 2000. p. 8, 2051.
17. Papanikolaou N, Prassopoulos P, Eracleous E, Maris T, Gogas C, Gourtsoyiannis N. Contrast-enhanced magnetic resonance cholangiography versus heavily T2-weighted magnetic resonance cholangiography. Invest Radiol 2001;36:682-686.
18. Prassopoulos P, Papanikolaou N, Maris T, Gogas C, Mouzas J, Gourtsoyiannis N. Development of contrast-enhanced virtual MR cholangioscopy feasibility study. Eur Radiol 2002;12:1438-1441.